These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2956019)

  • 1. Pulsatile insulin delivery: physiology and clinical implications.
    Bratusch-Marrain PR; Komjati M; Waldhäusl W
    Diabet Med; 1987; 4(3):197-200. PubMed ID: 2956019
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
    Unger RH; Orci L
    Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The "dawn" phenomenon].
    Levy Mizrahi I; Recasens Gràcia A
    Med Clin (Barc); 1985 Oct; 85(10):409-11. PubMed ID: 3908842
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans.
    Bratusch-Marrain PR; Komjati M; Waldhäusl WK
    Diabetes; 1986 Aug; 35(8):922-6. PubMed ID: 3525288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
    Starostina EG; Lobanova AM; Magomedova AK
    Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulsatory secretion of pancreatic hormones].
    Lefèbvre P; Paolisso G; Scheen A
    Journ Annu Diabetol Hotel Dieu; 1989; ():37-46. PubMed ID: 2668623
    [No Abstract]   [Full Text] [Related]  

  • 9. [Symposium: interrelations among hormones. 3. Spleen: effects of the digestive tract to insulin secretion (interrelation to glucagon)].
    Shima K; Kuroda K; Matsuyama T
    Nihon Naibunpi Gakkai Zasshi; 1970 Feb; 45():Suppl:32-3. PubMed ID: 5462204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Roles of endogenous insulin reserve and the counter-regulatory hormones in the various phases of juvenile diabetes mellitus].
    Kato K; Amamiya N; Asayama K
    Horumon To Rinsho; 1982 Sep; 30(9):911-9. PubMed ID: 6758986
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternative insulin delivery systems: how demanding should the patient be?
    Polonsky KS; Byrne MM; Sturis J
    Diabetologia; 1997 Jul; 40 Suppl 2():S97-101. PubMed ID: 9248709
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin sensitivity and hepatic glucose production: nycthemeral variations].
    Gautier JF; Cathelineau G
    Diabetes Metab; 1997 Nov; 23 Suppl 4():35-8. PubMed ID: 9463022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin secretion in obese and diabetic children evaluated with venous perfusion of glucose and stimulation with glucagon. preliminary data].
    Baratono S; Cerutti F; Carta Q; Ciancimino F
    Minerva Med; 1975 Mar; 66(19):946-52. PubMed ID: 1124147
    [No Abstract]   [Full Text] [Related]  

  • 14. [The period of initial remission in insulin-dependent diabetes. Effect of optimized insulin therapy].
    Vague P; Vialettes B; Lassmann V; Moulin JP
    Journ Annu Diabetol Hotel Dieu; 1984; ():73-84. PubMed ID: 6399541
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of glucagon in the artificial pancreas.
    Haidar A; Smaoui MR; Legault L; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):476-9. PubMed ID: 27138734
    [No Abstract]   [Full Text] [Related]  

  • 16. [Review: regulation of glucose metabolism].
    Yamada Y; Seino Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():153-8. PubMed ID: 12238041
    [No Abstract]   [Full Text] [Related]  

  • 17. [From insulin secretion to insulin therapy].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1240-6. PubMed ID: 9767787
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 19. Circadian rhythms of insulin needs and actions.
    Waldhäusl W
    Diabetes Res Clin Pract; 1989 May; 6(4):S17-24. PubMed ID: 2666058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon physiology and pathophysiology.
    Unger RH
    N Engl J Med; 1971 Aug; 285(8):443-9. PubMed ID: 4997492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.